Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
Launched by BOSTON CHILDREN'S HOSPITAL · Nov 13, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different amounts of clear fluids (like water or juice without pulp) consumed before surgery affect the contents of the stomach in children aged 13 to 17. According to guidelines, kids are usually advised to fast for 2 hours before elective procedures, but there's no specific guidance on how much clear fluid they should drink. In this study, participants will be randomly divided into four groups, each drinking a different amount of clear fluid (3 ml, 5 ml, 7 ml, or 10 ml per kilogram of their body weight) before their scheduled upper GI endoscopy, a type of procedure to look at the digestive system.
To be eligible for this trial, children should be classified as ASA I or II (indicating they're generally healthy), be between 13 and 17 years old, and scheduled for this elective procedure. They should also be fluent in English. The study will include 288 children in total, and during the endoscopy, doctors will measure how much fluid is left in their stomachs and its acidity. This information aims to help create better guidelines for fasting before surgery in the future, ensuring safer practices for young patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA classification: I and II
- • 13-17 years
- • IPD cases or the first OPD case
- • Scheduled for elective EGD procedure.
- • All participants, families or guardians will be fluent in English.
- Exclusion Criteria:
- • Emergent EGD procedures
- • Patients with active upper GI bleeding
- • Patients who received preoperative oral medication
- • Patients who are diagnosed as GERD, achalasia or suspected to have gastroparesis status such as uncontrolled diabetes or end stage kidney disease.
About Boston Children's Hospital
Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Patcharee Sriswasdi, MD, MPH
Principal Investigator
Boston Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials